DawnayA.Advanced glycation end products in peritoneal dialysis.Perit Dial Int1996; 16(Suppl 1): S50–3.
4.
WuG., BreborowiczA., KorybalskaK.Use of N-Acetyl-Glucosamine as osmotic agent for peritoneal dialysis.Perit Dial Int1996; 16(Suppl 2): S16.
5.
YungS., ColesG.A., WilliamsJ.D.The source and possible significance of hyaluronan in the peritoneal cavity.Kidney Int1994; 46: 527–33.
6.
JacksonR.L., BuschS.J., CardinA.D.Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes.Physiol Rev1991; 71: 481–532.
7.
ComperW.D., LaurentT.C.Physiological function of connective tissue polysaccharides.Physiol Rev1978; 58: 255–325.
8.
WeigelP.H., FrostS.J., LeBoeufR.The specific interaction between fibrin(ogen) and hyaluronan: possible consequences in haemostasis, inflammation and wound healing. In: EveredD., WhelanJ., eds. The biology of hyaluronan.Chichester: Wiley (Ciba Foundation Symposium 143) 1989; 248–64.
9.
WieczorowskaK., BreborowiczA., MartisL.Protective effect of hyaluronic acid against peritoneal injury.Perit Dial Int1995; 15: 81–3.
10.
WuG., Wieczorowska-TobisK., TamP.N-Acetyl Glucosamine (NAG) protects peritoneum of rats on chronic peritoneal dialysis.Perit Dial Int1997; 17: (Suppl 1): S10.
11.
BreborowiczA., RadkowskiM., KnapowskiJ.Effects of chondroitin sulphate on fluid and solute transport during peritoneal dialysis in rats.Perit Dial Int1991; 11: 351–4.
12.
HainH., KesselM.Aspects of new solutions for peritoneal dialysis.Nephrol Dial Transpl1987; 2: 67–72.
13.
LevinR.M., KriegerN.N., WiznlerR.J.Glucosamine and acetylglucosamine tolerance in man.J Lab Clin Med1961; 58: 927–32.
14.
WeidenS., WoodI.J.The fate of glucosamine hydrochloride injected intravenously in man.J Clin Pathol1958; 11: 343–9.
15.
KohnP., WinzlerR.J., HoffmanR.C.Metabolism of D-Glucosamine and N-Acetyl-D-glucosamine in the intact rat.J Biol Chem1962; 237: 304–8.
16.
BreborowiczA., WieczorowskaK., MartisL.Glycosaminoglycan chondroitin sulphate prevents loss of ultrafiltration during peritoneal dialysis in rats.Nephron1994; 67: 346–50.
17.
BazzatoG., FracassoA., ReG.Use of glycosaminoglycans to increase efficiency of long-term continuous peritoneal dialysis.Lancet1995; 346: 740–1.
18.
MistryC.D., MallickN.P., GokalR.Ultrafiltration with an isosmotic solution during long peritoneal dialysis exchanges.Lancet1987; 2: 178–82.
19.
Westergren-ThorssonG., OnnervikP.O., FransonL.A.Proliferation of cultured fibroblasts is inhibited by 1-iduronate-containing glycosaminoglycans.J Cell Physiol1991; 147: 523–30.
20.
GambaroG., FracassoA., ReG.Glycosaminoglycans improve peritoneal transport and fibrosis in rats with peritoneal sclerosis induced by diethylexylphtalate.J Am Soc Nephrol1994; 5: 448.
